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The vegetal biomembrane in the healing of chronic 
venous ulcers *
Biomembrana vegetal na cicatrização de úlceras venosas crônicas
Marco Andrey Cipriani Frade1 Raimunda Violante Campos de Assis2
Joaquim Coutinho Netto3 Thiago Antônio Moretti de Andrade4
Norma Tiraboschi Foss5
Abstract: BACKGROUND: The vegetal biomembrane has been used to treat cutaneous ulcers. 
OBJECTIVES: To assess the role of the vegetal biomembrane on the chronic venous ulcers treatment compared to
treatment with collagenase cream. 
METHODS: Fourteen patients were selected to be treated with vegetal biomembrane and 7 with Fibrase® (CON-
TROL), followed clinically and photographically by the Wound Healing Index by ImageJ during 120 days and bio-
psied on the 1st and 30th days for histological examination. 
RESULTS: The vegetal biomembrane was better in promoting healing of the ulcers, especially on the inflammatory
phase, confirmed by abundant exudation and wound debridement than the CONTROL group, on the 30th day.
There was a greater tendency to angiogenesis followed by re-epithelialization with highest wound healing index
on the 90th and 120th days. 
CONCLUSION: A combined analysis of clinical and histopathological findings suggests that the vegetal biomembra-
ne acted as a factor inducing wound healing, especially on the inflammatory phase, confirmed by abundant exu-
dation of the lesions promoting the transformation of the microenvironment of the chronic venous ulcers, and
also stimulating angiogenesis and subsequent re-epithelialization. 
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Resumo: FUNDAMENTOS: A biomembrana vegetal tem sido usada para tratamento de úlceras cutâneas. 
OBJETIVOS: Avaliar a ação da biomembrana vegetal no tratamento de úlceras venosas crônicas, comparando-a ao
tratamento à base de colagenase. 
MÉTODOS: Foram selecionados 14 pacientes tratados com biomembrana vegetal e sete com Fibrase® (grupo con-
trole), acompanhados clínico-fotograficamente pelo índice de cicatrização das úlceras (ICU) por 120 dias, por
meio do software ImageJ, e biopsiados no primeiro e 30º dias para estudo histopatológico. 
RESULTADOS: A biomembrana vegetal foi superior em relação ao controle na cicatrização das úlceras no 30º dia,
especialmente na fase inflamatória, confirmada pela exsudação abundante e pelo desbridamento. Houve tendên-
cia superior à angiogênese seguida de reepitelização com maiores ICUs no 90º e 120º dias. 
CONCLUSÃO: A análise conjunta dos achados clínicos e histopatológicos sugere que a biomembrana vegetal atuou
como um fator indutor da cicatrização, especialmente na fase inflamatória, confirmada pela exsudação abundan-
te das lesões, promovendo a transformação do microambiente das úlceras venosas crônicas e estimulando a
angiogênese e a posterior reepitelização. 
Palavras-chave: Cicatrização; Curativos biológicos; Látex; Úlcera da perna
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INTRODUCTION
Leg ulcers are a syndrome characterized by cir-
cumscript or irregular loss of tegument (epidermis
and/or dermis) that involves the lower extremities,
usually associated with dysfunction of the arterial or
venous vascular system. 1
The leg ulcers can be classified according to its
ethiology in ulcers due to venous insufficiency
(venous ulcers) corresponding to 80 to 85% of the
cases, arterial insufficiency (arterial ulcer) in 5 to 10%
and the remaining due to neuropathies (neuropathic
ulcer/diabetic foot). They can also be caused by trau-
ma, neoplasia, infections, panniculites and pyoderma
gangrenosum. 2
The prevalence of leg ulcers varies from 0.18%
to 1.3% of the adult population. 2,3 They develop most
commonly in the elderly population and its preva-
lence has been accentuating with the increase of life
expectance worldwide, becoming frequent on med-
ical daily life.  
The most popular treatment form of venous
ulcers is done with compressive bandages, introduced
by Unna (1885). 4 There are various types of dressings
used nowadays for this type of treatment, with differ-
ent indications, advantages and disadvantages. The
choice of dressing must be based essentially on factors
of efficacy and cost, so that the patient can maintain it
and thus achieve a satisfactory result, as the lesions
have a long period of evolution and the healing is
slow in most cases.  
The healing of the ulcers is a sequence of com-
plex biologic events that involve cellular and molecu-
lar processes, like the recruiting of leucocytes, inflam-
mation, angiogenesis and collagen deposition and re-
epithelialization. 5
Amongst the various therapeutic options for leg
ulcers, the vegetal biomembrane (VBM), from the
Hevea brasiliensis rubber tree, stands out. A biocom-
patible material, it was originally developed by the
Ribeirão Preto Medical School (Faculdade de Medicina
de Ribeirão Preto) - Universidade de São Paulo/Brasil.
Experiments with dogs showed that the material was
an important inducer of healing of the oesophageal
walls, with significant increase of the vascularisation
(neoangiogenesis), epithelialization (pseudostratified
epithelium), submucosal glandular neoformation and
formation of muscle fibers. 6 In flebopathic ulcers evi-
dent signs of stimulus to clinical and histological gran-
ulation were seen from the 15th day of treatment with
the VBM, with accentuated decrease of the symptoms,
including resolution of the pain. 7
There are current reports that the VBM per-
forms in various stages of the healing process of the
leg ulcers, like on the removal of the necrotic tissue
(debridement), proliferation of granulation tissue
(angiogenesis) and re-epithelialization, especially in
chronic ulcers of diabetic patients who have complica-
tions like diabetic microangiopathy, high blood pres-
sure and surgical difficulties.7-9 However little is
known about its real mechanism of action. 8
In view if the already demonstrated biocompat-
ibility of the VBM, preliminary results from case
reports and the lack of knowledge of its mechanism of
action, this study endeavours to evaluate the clinical
and histological alterations of the tissue repair of the
venous ulcers in the presence of the vegetal biomem-
brane from the Hevea brasiliensis rubber tree, com-
pared to the conventional treatment with colagenase
(Fibrase®). 7,8,9
PATIENTS AND METHODS 
Patients
After signing the consent form, 21 patients from
the Outpatients Clinic of leg ulcers of the Hospital
Universitário of the Universidade Federal de Juiz de
Fora - Juiz de Fora-MG and UBDS Alexandre Fleming -
Ribeirão Preto-SP were randomly selected and thus
distributed: 07 patients to the colagenase group
(CONTROL GROUP) and 14 to the vegetal biomem-
brane group (VBM GROUP). All patients were selected
by the presence of venous leg ulcer for more than 2
months, diagnosed according to clinical signs like:
varicose veins, hyperpigmentation, lipodermatoscle-
rosis, signs of eczema and pruritus. Patients with
uncontrolled high blood pressure, diabetes or other
systemic disease were excluded. The clinical data from
the patients and characteristics of the ulcers are
described on table 1. 
All the selection and participation of the
patients are in agreement with the norms established
by the Research Ethics Committee (REC) of the
 HCFMRP-USP according to the processes 4875/2001
and 11722/2003 respectively.
METHODS
The leg ulcers were cleaned with saline solu-
tion at 0.9% only and dried with gauze, getting ready
to receive the designated dressing. 
· Control dressing: daily topical application of
fibrinolisine associated with chloramphenicol
(Fibrase®), gauze and bandage.
· VBM dressing: performed every second day,
at home, with VBM applied to the bed of the ulcer, not
going over the limits of normal skin, gauze and band-
ages. 
Clinical evaluation
After filling up the protocol at consultation, the
ulcers were photographed on days 1, 30, 60 and 90
for clinical follow-up. The images were analysed by
An Bras Dermatol. 2012;87(1):45-51.
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the ImageJ 1.36 (U.S. National Institutes of Health,
Bethesda, MD, USA) software and subsequently the
normalized Ulcer Healing Index (UHI), described as
the ration of the difference between the initial area
and the area on day 30 over the initial area, as pro-
posed by Caetano et al., (2009), was calculated. 10-13
Additionally the semi-quantitative analyses of
the photographed images was performed by two differ-
ent observers who analysed the variables debris/necro-
sis, granulation tissue and re-epithelialization tissue
individually and adopted the crosses criteria: (+)
when the relative fraction of the variable corresponded
to up to 1/3 of the ulcerated area; (++) up to 2/3 and
(+++) more than 2/3 of the ulcerated area.
Histopathologic evaluation
The patients were biopsied on days 1st and 30th
of the treatment. A semi-quantitative analysis of the
specimens was chosen, using the crosses system as
described on chart 1. 
Statistical analyses
An exploratory statistical analysis of the vari-
ables age and duration of the patients´ ulcers was
done, considering the average, median and interquar-
tile deviations. For comparative analysis of the contin-
uous variables of the VBM and CONTROL groups the
Mann-Whitney test was used for non-parametric sam-
ples. For the categorical variables like progressive,
regressive or indifferent, the analysis between the
groups was done by the Mc Nemar test applied to the
results obtained as progressive and regressive. The
level of statistical significance was set at p<0.05.
RESULTS
Clinical Characterization 
In terms of location of the ulcers it was noted
that they were more frequent (85.8%) on the lower
distal third in both groups.  
As for the duration of the ulcers, the median on
the CONTROL GROUP was 108 months while on the
VBM it was 36 months (Table 1). 
In most patients of the CONTROL GROUP
(5/7), the leg ulcers corresponded to the first episode
and in 2 of them they were relapsing, while on the
VBM group only half corresponded to the first
episode (Table 1).
The period of treatment varied, and the
patients of the CONTROL GROUP were followed by
30 days with use of topical Fibrase®. On the VBM
GROUP the follow-up period was at least 30 days in all
Clinical Characteristics CONTROL GROUP (n = 7) VBM GROUP (n = 14)
n % n %
Average 61.6 - 64.1 -
Age (years) Median 70 - 64.5 -
1st Quartile 51.4 - 57 -
2nd Quartile 72 - 70.8 -
Sex Masculine - - 5 35.7
Feminine 7 100 9 64.3
Color White 3 42.9 11 78.6
Non white 4 57.1 3 21.4
Retired 6 85.7 8 57.1
Job Home duties - - 4 28.6
Peasant - - 2 14.3
Merchant 2 14.3 - -
Associated CVI 4 57.1 6 42.9
diseases CVI + HBP 3 42.9 8 57.1
Average 116 - 102.6 -
Duration Median 108 - 36 -
(months) 1st Quartile 24 - 8 -
2nd Quartile 204 - 105 -
Previous history   1st episode 5 71.4 7 50.0
of ulcers Relapse 2 28.6 7 50.0
TABLE 1: Clinical characterization of the patients and respective leg ulcers of the patients of the control and VBM groups 
CVI = Chronic Venous Insufficiency; HBP = High Blood Pressure
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ing the follow-up of the ulcers treated with VBM there
was a progressive increment of the UHI on the 60th,
90th and 120th day (Figure 1). 
On the semi-quantitative analysis it was
observed that only the variable fibrine/debris had a
statistically significant decrease on the VBM group
(p=0.013) in relation to the control group, besides a
tendency to progressive angiogenesis on the VBM
group, as described on table 2 and clinically demon-
strated with figure 2.  
patients, 60 days in 11 and 90 days in 5 patients.  
In terms of absolute areas it was noted that the
CONTROL GROUP had an average area of 9.37 cm2
and the VBM GROUP 13.19 cm2. Both groups were sta-
tistically similar (p=0.43) under the Mann-Whitney
test for non parametric samples.  
In terms of the analysis of the Ulcer Healing
Index (UHI), no statistically significant difference was
observed between the CONTROL and VBM GROUPS
(p=0.39) on the 30th day of treatment. However, dur-
An Bras Dermatol. 2012;87(1):45-51.
Parameter Crosses Location/pattern
Necrosis + On the upper 1/3 of the dermis
++ All of the dermis
+++ Up to the subcutaneous tissue
Inflammation + Borders of the lesion
++ 2/3 of the specimen
+++ The whole specimen
Angiogenesis + Capillary vessels with thin walls, 1 or 2 endothelial cells, borders of the lesion
++ Capillary vessels with wall thickness twice the previous, swollen endothelium, in 
2/3 of the lesion
+++ Thick wall vessels, swollen endothelium, in the whole specimen
Elastosis + Delicate elastic fibers, occasional
++ Thin and thick elastic fibers in equal proportion
+++ Thick elastic fibers in the whole specimen
Collagenic fibrosis + Delicate and occasional collagen fibers
++ Delicate and thick collagen fibers, occasional
+++ Thick collagen fibers, characterizing scar
Fibroblastic + Occasional fibroblasts. Predomination of acute inflammatory cells
proliferation ++ Fibroblasts and inflammatory cells in equal proportion  
+++ Fibroblastic predomination in the whole specimen 
CHART 1: Classification by crosses of the semi quantitative histopathological examination
FIGURE 1: Percentage of
reduction of the areas of
the ulcers on the CON-
TROL and VBM GROUPS
during follow-up 
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As for the semi-quantitative histological evalua-
tion before and after treatments, the histological evo-
lution of the ulcers was characterized as: regressive
(decrease of the number of crosses), progressive
(increase of the number of crosses) and indifferent,
and the results were analysed by the modified Mc
Nemar test. It was observed that the treatment with
VBM has a tendency to regression in terms of necrosis
and inflammation and progression in terms of angio-
genesis when compared with the CONTROL group.
(Table 3).
DISCUSSION
Both groups were homogeneous in terms of
age (p=0.45), location and duration of the ulcers
(p=0.18), although the CONTROL GROUP had a
slightly longer duration  than the VBM GROUP in 7.1
months, data that confirms the reports from Nelzen et
al., (1991) and Frade et al., (2005). 14,15
On the other hand, only 2.0 (28%) patients of
the control group were relapsing cases as opposed to
7.0 (50%) on the VBM group and the average area of
the ulcers on the CONTROL GROUP was slightly
smaller than that of the VBM GROUP (p=0.43).
On the clinic-photographic analysis of the treat-
ment of the ulcers the results showed the debriding
potential of the VBM by the regression of the variable
fibrine/debris higher that of the CONTROL GROUP
An Bras Dermatol. 2012;87(1):45-51.
Parameter Evolution CONTROL GROUP (n = 7) VBM GROUP (n = 14)
Number % Number %
Fibrine Regressive *  2 28.6 11 78.6
Progressive 1 14.3 1 7.0
Indifferent 4 57.0 2 14.0
Granulation Regressive  0 0 1 7,0
Progressive 3 43.0 8 56.0
Indifferent 4 57.0 5 35.0
Re-epithelialization Regressive  0 0 0 0
Progressive 3 43.0 6 42.0
Indifferent 4 57.0 8 56.0
TABLE 2: Result of the clinical–photographic analysis of the patients of the control and VBM groups
after 30 days of treatment
* p=0.013 for monocaudal tests.
FIGURE 2: Clinical evolution of the venous
ulcers of patients 1 and 8 of the VBM
GROUP and patient 2 of the CONTROL
GROUP 
LEGEND
A - Pre treatment (Initial)
B - Post-treatment (30 days)
C - 60 days
D - 120 days
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(p=0.013). This result was confirmed by the
histopathological study, with a tendency to regression
of the necrosis and inflammation variables on the
VBM GROUP also superior than the CONTROL
GROUP. 
The increase of the ulcer exudates at the begin-
ning of the treatment was reported and observed by
the patients on the VBM GROUP, which gradually
decreased with the use of dressings, probably related
to the inflammatory activity triggered by the VBM,
which increases the vascular permeability and conse-
quent intense exudation. As for its mechanism of
action it was proposed by Andrade (2007) that VBM
has an intense inflammatory activity, at the cost of
polymorphonucleocytes, histologically demonstrated
by the increase of the myeloperoxidase, as well as by
higher expression of IL-1β and iNOS at immunohisto-
chemistry. 16
VBM demonstrated a superior tendency to pro-
gression on the CONTROL of the induction of granu-
lation tissue, although without statistical difference.
At histopathological examination the results in rela-
tion to angiogenesis were similar between both
groups on the 30th day of follow-up.
The vascular neoformation (granulation) that
represents the initial stage of the tissue formation of
the healing process was well developed in many
patients of the VBM GROUP, reaching the point of
accentuated granulation (hypergranulation). On the
other hand, on the control group the granulation
stimulus was very mild and no case of hypergranula-
tion was observed. 
The clinical analyses of some patients of the
VBM GROUP, showed that the treatment led to an
intense vessel formation, represented by exuberant
granulation around the 30th day, with a light red color
granulation tissue (neoangiogenesis). However, with
the progression of the treatment the tissue became
more compact, accentuating the color to a darker red
(collagenesis) at around the second month of treat-
ment, which represents the tissue transformation pro-
moted by the VBM, highlighting its importance as an
inductor of healing tissue both on the tissue forma-
tion and on the tissue remodelling stages (Figure 2).
In terms of re-epithelialization, a phenomenon
related to the size of the ulcers, there was no statisti-
cal difference between the treatments on the CON-
TROL and VBM, certainly due to the short follow-up
period (30 days) of the CONTROL GROUP. However,
on the follow-up of the VBM GROUP patients beyond
the 30th day, Healing Ulcer Index higher than 0.5 on
the 90th and 120th day confirm the role of VBM on the
re-epithelialization stage of the chronic venous ulcers,
as previously described Frade et al., (2001). 15
It is important to stress that the main limitation
of the study was that the patients of the CONTROL
Parameter Evolution CONTROL VBM - 30 days VBM - 30 days
n. % n. % n. %
Necrosis Regressive 1 20 4 58.3 1 20
Progressive 0 0 1 8.3 3 60
Indifferent 4 80 7 33.3 1 20
Inflammation Regressive 2 40 6 50 5 100
Progressive 1 20 0 0 0 0
Indifferent 2 40 6 50 0 0
Angiogenesis Regressive 0 0 3 25 0 0
Progressive 2 40 5 41.7 2 40
Indifferent 3 60 4 33.3 3 60
Elastosis Regressive 0 0 2 16.7 0 0
Progressive 4 80 9 75 2 40
Indifferent 1 20 1 8.3 3 60
Collagenic Regressive 0 0 2 16.7 3 60
fibrosis Progressive 3 60 5 41.7 1 20
Indifferent 2 40 5 41.7 1 20
Fibroblastic Regressive 0 0 4 33.3 2 40
proliferation Progressive 4 80 3 25 1 20
Indifferent 1 20 5 41.7 2 40
TABLE 3: Histopathological analysis of the patients of the control and VBM groups (Mc Nemar Test) 
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GROUP did not want to continue the treatment based
on Fibrase® due to the expectation of using the alter-
native treatment (VBM), which impaired the clinical-
therapeutic analyses after the 30th day. 
As for the application of the dressing, the infor-
mation from the patients of the VBM GROUP about
the convenience of the application, due to less fre-
quent changes and, mostly, the non-adherence of the
dressing to the bed of the ulcer, related to the exuda-
tion induced by the VBM, associated with the absence
of pain and tissue damage during the changes, was
relevant. As for the CONTROL GROUP the changes
were done on a daily basis, accompanied by pain with
the removal of the dressing and, generally, traumatic
to the healing process.  
The joint analyses of the clinical and
histopathological findings suggest that the vegetal
biomembrane acted as an inductor factor of the heal-
ing process, especially on the inflammatory stage,
confirmed by the abundant exudates of the lesions,
promoting the transformation of the microenviron-
ment of the chronic venous ulcers, stimulus to angio-
genesis and subsequent re-epithelialization.
CONCLUSIONS
The vegetal biomembrane was important for
the induction of the healing, especially on the inflam-
matory stage, confirmed by the abundant exudation
and debridement of the ulcers in relation of the con-
trol treatment of chronic venous ulcers, which seems
to be directly related to the intense vascular formation
followed by re-epithelialization. 
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